Rizwan Khan appointed CEO, Thryvia™ consumer study reports encouraging digestive health benefits, and Whole-Cell Intelligence™ platform receives industry recognition ahead of SupplySide Global 2026.
NEW CASTLE, Del., Oct. 22, 2026 /PRNewswire/ — Superbrewed Food, Inc., a pioneer in precision postbiotics, today announced three significant milestones: the expansion of its executive leadership with the appointment of Rizwan Khan as Chief Executive Officer, encouraging results from a four-week consumer perception study of its flagship Thryvia™ postbiotic, and recognition with the Trailblazer Award at the MBOLD Bridge2Food Protein Innovation Pitch Slam.
Together, these developments highlight Superbrewed’s growing commercial momentum as the company prepares to engage customers and strategic partners at SupplySide Global 2026 in Las Vegas.
Superbrewed Expands Executive Leadership to Accelerate Commercial Growth
Superbrewed has strengthened its executive leadership with the appointment of Rizwan Khan as CEO. Khan brings more than three decades of senior executive and commercial leadership experience across the pharmaceutical, biotechnology, and nutrition industries. Previously, he served as Vice President and Global Head of Sales for Kerry Group’s Applied Health & Nutrition division and, most recently, as SVP Global Head of Sales at Nuritas.
Bryan Tracy, PhD, Co-Founder, now serves as President and remains a member of the Board of Directors. Together, Khan and Tracy bring world-class commercial, scientific, and operational expertise to accelerate Superbrewed’s next phase of growth.
“Superbrewed’s Whole-Cell Intelligence platform combines exceptional scientific innovation with scalable manufacturing to deliver highly differentiated ingredients with enormous commercial potential,” said Khan. “Having spent decades bringing innovative ingredients to market, I’m excited to partner with Bryan and the team to accelerate growth and deliver transformative solutions to the global nutrition industry.”
Thryvia Consumer Study Reports Encouraging Digestive Health Benefits
Superbrewed also announced positive findings from an independently conducted, four-week consumer perception study by Citruslabs evaluating daily consumption of 200 mg of Thryvia, its commercially available precision postbiotic.
After four weeks, 89% of participants (33 of 37) showed numerical improvement in their overall digestive health scores, with participants reporting the following benefits:
- 76% reported their stomach felt more at ease throughout the day.
- 73% reported less bloating or abdominal distension after eating.
- 70% reported improved overall digestive comfort.
“These results are particularly encouraging because consumers reported improvements across multiple dimensions of digestive comfort in as little as twenty-four hours,” said Tracy. “Combined with our growing understanding of Thryvia’s precise bioactive peptides and biological mechanisms, these findings strengthen our confidence in its potential to deliver meaningful health benefits.”
The open-label perception study captured participants’ self-reported experiences and was not designed to establish causality. Superbrewed is advancing randomized, placebo-controlled human clinical studies designed to evaluate these findings and determine whether Thryvia produces measurable causal benefits.
Unlike live probiotics, Thryvia does not require microbial viability to deliver biological activity. Its shelf stability, low inclusion rate, and compatibility with conventional food processing enable incorporation into dietary supplements, functional foods, and beverages.
Superbrewed Wins MBOLD Trailblazer Award for Whole-Cell Intelligence™
Superbrewed received the Trailblazer Award at the October 14 Protein Innovation Pitch Slam during the Bridge2Food North America Summit in Minneapolis.
Organized by MBOLD, Protein Industries Canada, and Bridge2Food, the international competition featured nine innovative companies from five countries. The judging panel included industry leaders representing Cargill, Target, AGT Food and Ingredients, Wageningen University & Research, and the Saskatchewan Food Industry Development Centre.
Tracy presented Superbrewed’s Whole-Cell Intelligence™ platform, which combines artificial intelligence, microbial discovery, molecular characterization, and industrial fermentation to develop and commercialize precision postbiotics with targeted biological functionality. The recognition highlights Superbrewed’s approach to unlocking the biological potential of naturally occurring microorganisms and translating scientific discovery into commercially scalable ingredients.
Meet Superbrewed at SupplySide Global 2026
Khan and Tracy will attend SupplySide Global in Las Vegas, October 27–30, and welcome opportunities to meet with customers and strategic partners interested in Thryvia, precision postbiotics, and Superbrewed’s broader innovation platform.
About Superbrewed Food, Inc.
Superbrewed Food is a biotechnology-driven nutrition company pioneering the discovery, development, and commercialization of precision postbiotics through its proprietary Whole-Cell Intelligence platform. Its flagship ingredient, Thryvia™, is a commercially available, shelf-stable postbiotic designed for digestive and immune health applications.
Learn more at www.superbrewedfood.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/superbrewed-accelerates-precision-postbiotics-commercialization-with-expanded-leadership-positive-human-study-results-and-mbold-innovation-award-302916971.html
SOURCE Superbrewed Food Inc.
